Cited by 1,203Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsDiabetes Management and Research

The DOI matches its Crossref record.

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

Kannel, W B, McGee, D L·1979·Diabetes Care

DOI 10.2337/diacare.2.2.120

Open this paper in CoChat — free account

Abstract

This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.

Integrity signals

Registry

Crossref · 10.2337/diacare.2.2.120

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 999

Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.002 · Cited by 78
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
Hiruma, S., Shigiyama, F., Hisatake, S., Mizumura, S., Shiraga, N., Hori, M., Ikeda, T., Hirose, T., & Kumashiro, N. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01228-3 · Cited by 80
“Background Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease (CVD) [1, 2].”
Background
Clinical Misconceptions Dispelled by Epidemiological Research
Kannel, W. B. (1995) · Circulation · doi:10.1161/01.cir.92.11.3350 · Cited by 73
Self-citation
Role of Angiotensin II in Altered Expression of Molecules Responsible for Coronary Matrix Remodeling in Insulin-Resistant Diabetic Rats
Jesmin, S., Sakuma, I., Hattori, Y., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000094235.78783.d1 · Cited by 74
Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013)
on Behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association, Jung, C. H., Chung, J. O., Han, K., Ko, S.-H., Ko, K. S., & Park, J.-Y. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0482-6 · Cited by 74
Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Streptozotocin-Induced Diabetic Rats
Dave, K. R., Tamariz, J., Desai, K., Brand, F. J., Liu, A., Saul, I., Bhattacharya, S. K., & Pileggi, A. (2011) · Stroke · doi:10.1161/strokeaha.110.594937 · Cited by 73
Diabetic Heart Muscle Disease
Uusitupa, M. I. J., Mustonen, J. N., & Airaksinen, J. K. E. (1990) · Annals of Medicine · doi:10.3109/07853899009147274 · Cited by 69
Disturbances of insulin in British Asian and white men surviving myocardial infarction.
Hughes, L. O., Cruickshank, J. K., Wright, J., & Raftery, E. B. (1989) · BMJ · doi:10.1136/bmj.299.6698.537 · Cited by 72
Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?
Christensen, R. H., von Scholten, B. J., Lehrskov, L. L., Rossing, P. R., & Jørgensen, P. G. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820928824 · Cited by 72
Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
Yu, Y., Ohmori, K., Chen, Y., Sato, C., Kiyomoto, H., Shinomiya, K., Takeuchi, H., Mizushige, K., & Kohno, M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.050 · Cited by 71
“t D e a t c bnormal glucose tolerance is a major risk factor for ardiovascular diseases (1).”
Background
Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in Type 1 and Type 2 diabetic patients
Rigla, M., Sánchez‐Quesada, J. L., Ordóñez‐Llanos, J., Prat, T., Caixàs, A., Jorba, O. J., Serra, J. R., de Leiva, A., & Pérez, A. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80041-4 · Cited by 71
Coronary Artery Calcium Score Compared with Cardio-Ankle Vascular Index in the Prediction of Cardiovascular Events in Asymptomatic Patients with Type 2 Diabetes
Chung, S., Yang, C.-C., Chen, C.-C., Hsu, Y.-C., & Lei, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.29926 · Cited by 71
Diabetes Impairs Angiogenesis and Induces Endothelial Cell Senescence by Up-Regulating Thrombospondin-CD47-Dependent Signaling
Bitar, M. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030673 · Cited by 74
Recent advances in the management of type 2 diabetes mellitus: a review
Srinivasan, B. T., Jarvis, J., Khunti, K., & Davies, M. J. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.067918 · Cited by 70
Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population.
Cowie, C. C., Howard, B. V., & Harris, M. I. (1994) · Circulation · doi:10.1161/01.cir.90.3.1185 · Cited by 70
The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery
Juul, A. B., Wetterslev, J., Kofoed‐Enevoldsen, A., Callesen, T., Jensen, G. B., & Gluud, C. N. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.030 · Cited by 68
Exercise and Type 1 Diabetes
Lu, X., & Zhao, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_7 · Cited by 77
Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study
Dale, A. C., Nilsen, T. I. L., Vatten, L. J., Midthjell, K., & Wiseth, R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm447 · Cited by 67
Stroke in diabetic and non‐diabetic patients: Course and prognostic value of admission serum glucose
Stöllberger, C., Exner, I., Finsterer, J., et al. (2005) · Annals of Medicine · doi:10.1080/07853890510037356 · Cited by 69
“3667 Pulmonary embolism n (%) 5 (1) 4 (1) 0.”
Influential
Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes
Atabek, M. E., Kurtoğlu, S., Pirgon, Ö., & Baykara, M. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.03.004 · Cited by 68
“Diabetes mellitus is established as an independent risk factor for cardiovascular morbidity and mortality in adults and children with type 2 diabetes [1,2].”
Background
Hepatocyte Growth Factor Prevents Endothelial Cell Death Through Inhibition of bax Translocation From Cytosol to Mitochondrial Membrane
Nakagami, H., Morishita, R., Yamamoto, K., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2604 · Cited by 68
“Diabetes is characterized by the premature development of microvascular and macrovascular diseases (2), and hyperglycemia is an independent risk factor for the development of cardiovascular disease.”
Background
MECHANISMS IN ENDOCRINOLOGY: Regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
Heppner, K. M., & Tong, J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0183 · Cited by 68
Co-morbidities in heart failure
van Deursen, V. M., Damman, K., van der Meer, P., Wijkstra, P. J., Luijckx, G. J., van Beek, A. P., van Veldhuisen, D. J., & Voors, A. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9370-7 · Cited by 67
“The Framingham and SOLVD studies found that diabetic patients were more obese, had impaired lipid and glucose profiles and had more hypertension [45, 46].”
Method
Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old
Bouchard, A., Sanz, N., Botvinick, E. H., PHILLIPS, N. R., Heilbron, D. C., Byrd, B. F., Karam, J. H., & Schiller, N. B. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80691-6 · Cited by 66
Transferrin Modifications and Lipid Peroxidation: Implications in Diabetes Mellitus
Campenhout, A. V., Campenhout, C. M. V., Lagrou, A., & Manuel‐y‐Keenoy, B. (2003) · Free Radical Research · doi:10.1080/10715760310001600390 · Cited by 67
“Patients with diabetes mellitus have both a higher incidence and mortality of cardiovascular disease.([1,2]) As suggested by the higher concentrations of”
Background
Effects of statins on the vasculature
Sowers, J. R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03269-1 · Cited by 67
The Role of the Health Belief Model in Amputees' Self-Evaluation of Adherence to Diabetes Self-Care Behaviors
Pham, D. T., Fortin, F., & Mf, T. (1996) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179602200205 · Cited by 66
Mitochondrial Respiratory Impairment in Streptozotocin-Induced Diabetic Rat Heart
Tomita, M., Mukae, S., Geshi, E., Umetsu, K., Nakatani, M., & Katagiri, T. (1996) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.60.673 · Cited by 65
Association between the severity of diabetes mellitus and coronary arterial atherosclerosis
Lemp, G. F., Zwaag, R. V., Hughes, J. P., Maddock, V., Kroetz, F. W., Ramanathan, K. B., Mirvis, D. M., & Sullivan, J. M. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90344-4 · Cited by 66
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers
Angoff, R., Mosarla, R. C., & Tsao, C. W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709396 · Cited by 64
Carotid intima media thickness in type 2 diabetes mellitus with ischemic stroke
Kota, S., Mahapatra, G., Kota, S., Syed, N. A., Tripathy, P., Jammula, S., & Modi, K. D. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113767 · Cited by 65
“The objective of this study was to fi nd out the cut-off point for CIMT for ischemic stroke in patients with type 2 diabetes mellitus (T2DM) and to correlate CIMT with various parameters like smoking, hypertension, lipid profi le and duration of T2DM.”
MethodInfluential
Protective effect of tannins from Ficus racemosa in hypercholesterolemia and diabetes induced vascular tissue damage in rats
Ravichandiran, V., Nirmala, S., & Ahamed, H. N. (2012) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(12)60061-3 · Cited by 65
“Lowering of blood glucose levels and serum lipid levels through dietary or drug therapy seems to be associated with a decrease in the risk of vascular disease and related complications[37-39].”
Background
Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea
Tamura, A., Kawano, Y., Watanabe, T., & Kadota, J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.020 · Cited by 64
Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota
Tierney, E. F., Geiss, L. S., Engelgau, M. M., Thompson, T. J., Schaubert, D. R., Shireley, L. A., Vukelic, P. J., & McDonough, S. L. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.84 · Cited by 65
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: Association with increased plasminogen activator inhibitor-1
Aso, Y., Matsumoto, S., Fujiwara, Y., Tayama, K., Inukai, T., & Takemura, Y. (2002) · Metabolism · doi:10.1053/meta.2002.31334 · Cited by 65
The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes
Uusitupa, M. I. J., Laitinen, J., Siitonen, O., Vanninen, E. J., & Pyörälà, K. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90118-o · Cited by 65
Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy
Ballotari, P., Venturelli, F., Greci, M., Rossi, P. G., & Manicardi, V. (2017) · International Journal of Endocrinology · doi:10.1155/2017/6039356 · Cited by 68
Current concepts of cardiovascular diseases in diabetes mellitus
Raza, J. A., & Movahed, A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00510-7 · Cited by 63
Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population
Visser, C., Bilo, H. J. G., Thomsen, T. F., Groenier, K. H., & Jong, B. M. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01137.x · Cited by 67
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
Karwi, Q. G., Sun, Q., & Lopaschuk, G. D. (2021) · Cells · doi:10.3390/cells10113259 · Cited by 68
Insulin-Induced Decreases in Aortic Wave Reflection and Central Systolic Pressure Are Impaired in Type 2 Diabetes
Tamminen, M., Westerbacka, J., Vehkavaara, S., & Yki‐Järvinen, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2314 · Cited by 62
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2 , in subclinical cardiovascular disease in the Diabetes Heart Study
Burdon, K. P., Lehtinen, A. B., Langefeld, C. D., et al. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.021 · Cited by 63
Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States
Losina, E., Hyle, E. P., Borre, E. D., Linas, B. P., Sax, P. E., Weinstein, M. C., Rusu, C., Ciaranello, A. L., Walensky, R. P., & Freedberg, K. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix547 · Cited by 62
Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus
Werner, G. S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00187-8 · Cited by 62
“Inclusion criteria were: ( 1 ) duration of the occlusion P2 weeks; (2) no antegrade opacification of the distal vessel (TIMI 0 coronary flow); (3) spontaneously visible collaterals.”
Background
Diabetes-Induced Vascular Hypertrophy Is Accompanied by Activation of Na + -H + Exchange and Prevented by Na + -H + Exchange Inhibition
Jandeleit-Dahm, K. A. M., Hannan, K. M., Farrelly, C. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1133 · Cited by 62
Diabetes Mellitus in a Subgroup of Older Mexicans: Prevalence, Association with Cardiovascular Risk Factors, Functional and Cognitive Impairment, and Mortality
Rodríguez‐Saldaña, J., Morley, J. E., Reynoso, M. T. M., Medina, C. A., Salazar, P., de la Cruz, E., & Torres, A. L. N. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50016.x · Cited by 62
Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells
Lee, Y. J., Kang, D. G., Kim, J. S., et al. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.11.004 · Cited by 61
Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study
Idzior−Waluś, B., Mattock, M. B., Solnica, B., Stevens, L. K., Fuller, J., & the EURODIAB IDDM Complications Study Group (2001) · Diabetic Medicine · doi:10.1046/j.0742-3071.2001.00571.x · Cited by 62
Predicting CHD risk in patients with diabetes mellitus
Yeo, W. W., & Yeo, W. W. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00510.x · Cited by 61
Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables
Welborn, T. A., Knuiman, M. W., McCann, V. J., et al. (1984) · Diabetologia · doi:10.1007/bf00276969 · Cited by 61
“that the conventional risk factors in the populat ion operate also for diabetic patients [4-6].”
BackgroundInfluential
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis
Butalia, S., Leung, A. A. C., Ghali, W. A., & Rabi, D. M. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-25 · Cited by 59
“” There is widespread acceptance that diabetes is a major risk factor for cardiovascular disease [2,32-34], but there have been varying estimates of absolute risk [3].”
Background
The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock
Kengne, A. P., Turnbull, F., & MacMahon, S. W. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.02.010 · Cited by 65
Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease
Rafeh, R. W., Viveiros, A., Oudit, G. Y., & EL‐Yazbi, A. F. (2020) · Clinical Science · doi:10.1042/cs20190227 · Cited by 63
The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics
Houston, M. C. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90816-2 · Cited by 60
d-α-Tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity
Lee, I. K., Koya, D., Ishi, H., Kanoh, H., & King, G. L. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00048-0 · Cited by 60
Atypical presentation of acute and chronic coronary artery disease in diabetics
Khafaji, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.802 · Cited by 57
Obesity, Diabetes, and Coronary Risk in Women
Pradhan, A. D., Skerrett, P. J., & Manson, J. E. (2002) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670200900605 · Cited by 58
Opposite effects of high glucose on MMP‐2 and TIMP‐2 in human endothelial cells
Ho, F. M., Liu, S., Lin, W., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21192 · Cited by 58
The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94
Colhoun, H. M., Dong, W., Barakat, M. T., Mather, H. M., & Poulter, N. R. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00017.x · Cited by 57
Exercise in the Management of Type 1 Diabetes Mellitus
Steppel, J. H., & Horton, E. S. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1027302112655 · Cited by 57
Prevention of cardiovascular disease in the elderly
Kannel, W. B., Doyle, J. T., Shephard, R. J., Stamler, J., & Vokonas, P. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80443-6 · Cited by 57
Self-citation
Monocyte Chemoattractant Protein-1 – a major contributor to the inflammatory process associated with diabetes
Butoi, E. D., & Simionescu, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450601094672 · Cited by 57
“The fact that glucose uptake by vascular cells is largely insulin-independent renders these cells vulnerable to glucose-induced injury when the extracellular glucose concentration is elevated (Kannel & McGee, 1979; Diabetes Control and Complications Trial, 1993; Gibbons & Dzau, 1994).”
Background
One-Hour Postload Plasma Glucose and Risks of Fatal Coronary Heart Disease and Stroke among Nondiabetic Men and Women: The Chicago Heart Association Detection Project in Industry (CHA) Study
Orencia, A. J., Daviglus, M. L., Dyer, A. R., Walsh, M. K., Greenland, P., & Stamler, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00201-1 · Cited by 57
Dyslipoproteinemia and Diabetes
Orchard, T. J. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30330-x · Cited by 57
The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment
Hyre, A. D., Fox, C. S., Astor, B. C., Cohen, A. J., & Muntner, P. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.09.017 · Cited by 55
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes
Bachmann, K. N., & Wang, T. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4442-9 · Cited by 56
Optimizing Cardiovascular Outcomes in Diabetes Mellitus
Sobel, B. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.002 · Cited by 56
Factors associated with postoperative complications in diabetics after biliary tract surgery
Sandler, R. S., Maule, W. F., & Baltus, M. E. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90452-x · Cited by 56
Hypertension and Diabetes
DEEDWANIA, P. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1585 · Cited by 55
Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis
Park, Y. M., Kashyap, S. R., Major, J. A., & Silverstein, R. L. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.74 · Cited by 62
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.003 · Cited by 59
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity
Molenaar, E. A., Hwang, S., Vasan, R. S., Grobbee, D. E., Meigs, J. B., D’Agostino, R. B., Levy, D. A., & Fox, C. S. (2008) · Diabetes Care · doi:10.2337/dc07-2413 · Cited by 56
“Rates of CVD associated with type 2 diabetes are high (18), and recent increases in chronic kidney disease may be due in part to increases in obesity and diabetes (2).”
Potential benefits of hyperbaric oxygen therapy on atherosclerosis and glycaemic control in patients with diabetic foot.
Karadurmuş, N., Şahi̇n, M., Taşçı, C., Naharci, I., Öztürk, C., Ilbasmis, S., Dulkadir, Z., Şen, A., & Sağlam, K. (2010) · PubMed · Cited by 54
Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene
Koike, H., Morishita, R., Iguchi, S., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0754fje · Cited by 55
“Although diabetes mellitus (DM) is characterized by the premature development of microvascular and macrovascular disease (17), peripheral neuropathy is common and ultimately accounts for significant morbidity among patients with diabetes.”
Background
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention
Serruys, P. W. J. C., de Feyter, P. J., Macaya, C., Kokott, N., Puel, J., Vrolix, M., Branzi, A., Bertolami, M. C., Jackson, G., Strauss, B. H., et al. (2006) · Cited by 54
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease
Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., LENNON, L. T., & Whincup, P. H. (2004) · Diabetologia · doi:10.1007/s00125-004-1491-7 · Cited by 54
Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease
Harpaz, D., Gottlieb, S., Graff, E., Boyko, V., Kishon, Y., & Behar, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00328-3 · Cited by 52
Plasma levels of MMP-2, MMP-9 and TIMP-1 are not associated with arterial stiffness in subjects with type 2 diabetes mellitus
Papazafiropoulou, A. K., Perrea, D. N., Moyssakis, I. E., Kokkinos, A. D., Katsilambros, N. L., & Tentolouris, N. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.10.004 · Cited by 53
Coronary heart disease mortality amongst non‐insulin‐dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17‐year follow up
Vilbergsson, S., Vilbergsson, S., Sigurðsson, G., Sigurðsson, G., Sigvaldason, H., & Sigfússon, N. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00368.x · Cited by 53
Weight loss and metabolic outcomes of bariatric surgery in men versus women — A matched comparative observational cohort study
Kennedy-Dalby, A., Adam, S., Ammori, B. J., & Syed, A. A. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.10.020 · Cited by 53
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
Wu, L., Vikramadithyan, R. K., Yu, S., Pau, C., Hu, Y., Goldberg, I. J., & Dansky, H. M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600146-jlr200 · Cited by 53
“rates (5, 6), and cell culture models that demonstrate adverse effects of hyperglycemia on vascular cells (as re-”
Background
Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection
Huang, J., Yu, M., Dai, C., Hsieh, M., Hwang, S., Hsiao, P., Lee, L., Lin, Z., Chen, S., Hsieh, M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01996.x · Cited by 53
“In addition to future DM development, the prediabetic condition also carries a risk for cardiovascular disease (11, 12).”
Background
Humic acid-assisted synthesis of stable copper nanoparticles as a peroxidase mimetic and their application in glucose detection.
Wang, N., Li, B.-C., Qiao, F., Sun, J.-C., Fan, H., & Ai, S. (2015) · Journal of materials chemistry. B · doi:10.1039/c5tb00684h · Cited by 46
The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis
Marso, S. P., Kennedy, K. F., House, J. A., & McGuire, D. K. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109353367 · Cited by 51
Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes
Nelson, A. J., Peterson, E. D., & Pagidipati, N. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.001 · Cited by 53
Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus
Hendra, T. J., & Betteridge, D. J. (1989) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(89)90003-3 · Cited by 52
Iron-binding antioxidant capacity is impaired in diabetes mellitus
Campenhout, A. V., Campenhout, C. V., Lagrou, A., Moorkens, G. H., Block, C. E. M. D., & Manuel‐y‐Keenoy, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.010 · Cited by 51
Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes
Wells, B. J., Jain, A., Arrigain, S., Yu, C., Rosenkrans, W. A., & Kattan, M. W. (2008) · Diabetes Care · doi:10.2337/dc08-1047 · Cited by 51
Rehabilitation Services Use and Patient-Reported Outcomes Among Older Adults in the United States
Gell, N., Mroz, T. M., & Patel, K. V. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2017.02.027 · Cited by 51
Risk for Coronary Artery Disease and Morbid Preeclampsia: A Commentary
Ness, R. B., & Hubel, C. A. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.02.007 · Cited by 51
Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves?
Massing, M., Foley, K., Sueta, C., Chowdhury, M., Biggs, D. P., Alexander, C. M., & Simpson, R. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.991 · Cited by 50
Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction
Vaccarino, V., Parsons, L. S., Every, N. R., Barron, H. V., & Krumholz, H. M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00800-6 · Cited by 51
Nonfasting Serum Glucose and the Risk of Fatal Stroke in Diabetic and Nondiabetic Subjects
Håheim, L. L., Holme, I., Hjermann, I., & Leren, P. (1995) · Stroke · doi:10.1161/01.str.26.5.774 · Cited by 51
Colorimetric determination of glucose in solution and via the use of a paper strip by exploiting the peroxidase and oxidase mimicking activity of bimetallic Cu-Pd nanoparticles deposited on reduced graphene oxide, graphitic carbon nitride, or MoS2 nanosheets
Darabdhara, G., Boruah, P. K., & Das, M. R. (2018) · Microchimica Acta · doi:10.1007/s00604-018-3112-z · Cited by 50
A Cloud Based Four-Tier Architecture for Early Detection of Heart Disease with Machine Learning Algorithms
Ahmed, M. R., Mahmud, S. M. H., Hossin, M. A., Jahan, H., & Noori, S. R. H. (2018) · IEEE International Conference on Computer and Communications (ICCC) · doi:10.1109/compcomm.2018.8781022 · Cited by 53
“There are some major heart disease risk factors such as peculiar glucose metabolism, extreme blood pressure, dyslipidemia, smoking, lack of physical exercise and growing age are well recognized [7].”
Background
Current Awareness
Roth, J. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200007/08)16:4
How deadly is the “deadly quartet”?
Sprecher, D. L., & Pearce, G. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00867-6 · Cited by 49
Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance
Howard, B. V., Hsia, J. A., Ouyang, P., Voorhees, L. V., Lindsay, J. M., Silverman, A., Alderman, E. L., Tripputi, M., & Waters, D. D. (2004) · Circulation · doi:10.1161/01.cir.0000134955.93951.d5 · Cited by 50
How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications
Girard, D., & Vandiedonck, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.991716 · Cited by 55
Cause-specific mortality in a cohort of patients with diabetes mellitus A population-based study in Sweden
Weiderpass, E. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00342-0 · Cited by 49

Authors: Kannel, W. B., & McGee, D. L.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 1979-03-01
Volume: 2
Issue: 2
Pages: 120-126
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.2.2.120
OpenAlex: W2059537042
Cited by: 1,203
References: 0
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
FWCI: 4.07
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
MeSH terms: Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks